piperazine has been researched along with Liver Neoplasms in 2 studies
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, XY | 1 |
| Jiao, H | 1 |
| Zhang, JK | 1 |
| Tian, XY | 1 |
| Guo, DF | 1 |
| Gao, J | 1 |
| Jia, MQ | 1 |
| Song, J | 1 |
| Zhang, SY | 1 |
| Fu, XJ | 1 |
| Tang, HW | 1 |
| İbiş, K | 1 |
| Nalbat, E | 1 |
| Çalışkan, B | 1 |
| Kahraman, DC | 1 |
| Cetin-Atalay, R | 1 |
| Banoglu, E | 1 |
2 other studies available for piperazine and Liver Neoplasms
| Article | Year |
|---|---|
Discovery of novel arylamide derivatives containing piperazine moiety as inhibitors of tubulin polymerisation with potent liver cancer inhibitory activity.
Topics: Apoptosis; Binding Sites; Humans; Liver Neoplasms; Piperazine; Tubulin; Tubulin Modulators | 2023 |
Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Scr | 2021 |